Synthetic analogs of an Entamoeba histolytica glycolipid designed to combat intracellular Leishmania infection

Siew Ling Choy, Hannah Bernin, Toshihiko Aiba, Eugenia Bifeld, Sarah Corinna Lender, Melina Mühlenpfordt, Jill Noll, Julia Eick, Claudia Marggraff, Hanno Niss, Nestor González Roldán, Shinji Tanaka, Masato Kitamura, Koichi Fukase, Joachim Clos, Egbert Tannich, Yukari Fujimoto, Hannelore Lotter

研究成果: Article査読

5 被引用数 (Scopus)

抄録

Intracellular pathogens belonging to the genus Leishmania have developed effective strategies that enable them to survive within host immune cells. Immunostimulatory compounds that counteract such immunological escape mechanisms represent promising treatment options for diseases. Here, we demonstrate that a lipopeptidephosphoglycan (LPPG) isolated from the membrane of a protozoan parasite, Entamoeba histolytica (Eh), shows considerable immunostimulatory effects targeted against Leishmania (L.) major, a representative species responsible for cutaneous leishmaniasis (CL). Treatment led to a marked reduction in the number of intracellular Leishmania parasites in vitro, and ameliorated CL in a mouse model. We next designed and synthesized analogs of the phosphatidylinositol anchors harbored by EhLPPG; two of these analogs reproduced the anti-leishmanial activity of the native compound by inducing production of pro-inflammatory cytokines. The use of such compounds, either alone or as a supportive option, might improve the currently unsatisfactory treatment of CL and other diseases caused by pathogen-manipulated immune responses.

本文言語English
論文番号9472
ジャーナルScientific reports
7
1
DOI
出版ステータスPublished - 2017 12月 1

ASJC Scopus subject areas

  • 一般

フィンガープリント

「Synthetic analogs of an Entamoeba histolytica glycolipid designed to combat intracellular Leishmania infection」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル